Affiliations 

  • 1 National Repository for Microalgae and Cyanobacteria - Freshwater (DBT: Govt. of India), Department of Microbiology, Bharathidasan University, Tiruchirappalli, India; Division of Bioengineering, Incheon National University, Republic of Korea. Electronic address: [email protected]
  • 2 National Repository for Microalgae and Cyanobacteria - Freshwater (DBT: Govt. of India), Department of Microbiology, Bharathidasan University, Tiruchirappalli, India
  • 3 Department of Medical Microbiology, University of Malaya, Malaysia
  • 4 Department of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, United Arab Emirates
  • 5 National Repository for Microalgae and Cyanobacteria - Freshwater (DBT: Govt. of India), Department of Microbiology, Bharathidasan University, Tiruchirappalli, India; Department of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, United Arab Emirates. Electronic address: [email protected]
Microb Pathog, 2018 Jan;114:323-327.
PMID: 29229504 DOI: 10.1016/j.micpath.2017.11.043

Abstract

Chitosan is the second most abundant polymer obtained from the byproduct of seafood. Chitosan and its derivatives and chitosan loaded drugs are the recent area of interest against microbial pathogenesis. The cationic chitosan nanoparticles (ChNPs) interact with the anionic surfaces of the microbial cell membrane, which promotes antimicrobial activity. Although, ChNPs are potential against pathogenic microbes, selection of adaptable, suitable and cost effective synthesis method is much important. In the present study, ChNPs were synthesized adopting ionic gelation using sodium tripolyphosphate as a cross linking agent and characterized by FTIR, DLS, SEM and TEM analysis. ChNPs were investigated for antimicrobial activity against bacterial (Escherichia coli and Staphylococcus aureus) and fungal (Candida albicans) pathogens. ChNPs showed bactericidal activity at the lower minimum inhibitory concentration of about 40-80 μg mL-1. Interestingly, ChNPs exhibits biocompatible antioxidant property by inhibiting DPPH free radicals at 76% and also proven to be a potential candidate against the microbial pathogenesis with an inevitable applications in biomedicine.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.